In malignant melanoma, targeted inhibition of HIF-1α induced high levels of CCL2 and CCL5 expression and then increased the invasion of tumor-killing NK cells, CD3+, CD4+, and CD8+ T cells in tumor tissues [18]. The gene discussed is HIF1A; the disease is neoplasm.